Search Results - "Bursagova, B I"

Refine Results
  1. 1

    Assessment of spasticity-related pain in cerebral palsy and the efficacy of its treatment with incobotulinumtoxin A (literature review) by Kurenkov, A. L., Bursagova, B. I., Artemenko, A. R.

    “…Pain in cerebral palsy (CP) occurs in 30–60% of cases. Pain associated with spasticity (PAS) is one of the most common causes of pain syndrome in cerebral…”
    Get full text
    Journal Article
  2. 2

    Levels of circulating cytokines in children with multiple sclerosis with different effectiveness of interferon therapy by Radygina, T. V., Petrichuk, S. V., Kurbatova, O. V., Kuptsova, D. G., Fisenko, A. P., Semikina, E. L., Freydlin, E. V., Abdullaeva, L. M., Bursagova, B. I.

    Published in Allergologiâ i immunologiâ v pediatrii (08-01-2024)
    “…Multiple sclerosis (MS) is a chronic, demyelinating disease that leads to disability. Understanding the etiology of MS contributes to the development of…”
    Get full text
    Journal Article
  3. 3

    Features of parameters of cellular immune depending on the activity of foci of demyelination in children with multiple sclerosis by Radygina, T. V., Kuptsova, D. G., Kurbatova, O. V., Petrichuk, S. V., Semikina, E. L., Fisenko, A. P., Abdullaeva, L. M., Bursagova, B. I.

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (01-06-2023)
    “…MS is a common disease of the central nervous system that leads to disability and reduced quality of life. The debut of disease in 3-5% of patients occurs in…”
    Get full text
    Journal Article
  4. 4

    IncobotulinumtoxinA in the treatment of sialorrhea in patients with infantile cerebral palsy by Kurenkov, A. L., Kuzenkova, L. M., Chernikov, V. V., Bursagova, B. I., Nezhelskaya, A. A., Artemenko, A. R.

    “…Sialorrhea is a severe medical problem that is difficult to treat, which can lead to serious complications. In almost all cases, chronic sialorrhea is…”
    Get full text
    Journal Article
  5. 5
  6. 6

    EXPERIENCE OF THE TYPE A BOTULINUM TOXIN TYPE (ONABOTULINUMTOXINA) DRUG IN TREATMENT OF CEREBRAL PALSY PATIENTS by A. L. Kurenkov, O. A. Klochkova, B. I. Bursagova, L. M. Kuzenkova, A. R. Artemenko, I. V. Falkovsky

    Published in Medicinskij sovet (01-12-2017)
    “…Injections of botulinum toxin type A (BTA) are regarded as one of the basic methods to treat cerebral palsy (CP). The article discusses issues unique mechanism…”
    Get full text
    Journal Article
  7. 7

    CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY IN CHILDREN: DIAGNOSIS AND TREATMENT by Kurenkov, А.L., Kuzenkova, L. M., Nikitin, S. S., Bursagova, B. I.

    Published in Voprosy sovremennoĭ pediatrii (05-10-2014)
    “…Chronic inflammatory demyelinating polyneuropathy (CIDP) in children is a rare autoimmune disease of the peripheral nervous system. The article analyzes…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    EХPERIENCE IN INTERFERON β-1A USE FOR TREATMENT OF MULTIPLE SCLEROSIS IN CHILDREN by Kuzenkova, L. M., Pak, L. A., Studenikin, V.M., Shatilova, N. N., Bursagova, B. I., Smirnova, I. E.

    Published in Voprosy sovremennoĭ pediatrii (19-09-2013)
    “…Aim: to evaluate the impact of subcutaneous interferon β-1a on matrix metalloproteinases 3, 8, 9 (MMP), cytokines (tumor necrosis factor α — TNF α, and…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Multilevel botulinum toxin treatment in severe spastic forms of cerebral palsy (GMFCS IV-V) by Kurenkov, A L, Klochkova, O A, Kuzenkova, L M, Bursagova, B I, Karimova, Kh M

    “…To evaluate the most typical target muscles and dosages for the first and repeated botulinum toxin A (BTA) injections in cerebral palsy (CP) patients with…”
    Get more information
    Journal Article
  13. 13

    Specific features of chronic inflammatory demyelinating polyneuropathy in children by A. L. Kurenkov, S. S. Nikitin, B. I. Bursagova, L. M. Kuzenkova

    Published in Nervno-myshechnye bolezni (01-02-2015)
    “…Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune peripheral neuropathy that affects both adults and children. The basis for the paper…”
    Get full text
    Journal Article
  14. 14

    Electromyography in diagnostic of median nerve lesion in carpal tunnel syndrome of children with mucopolysaccharidoses by A. L. Kurenkov, T. V. Podkletnova, L. M. Kuzenkova, B. I. Bursagova, S. S. Nikitin, A. K. Gevorkyan, N. D. Vashakmadze

    Published in Nervno-myshechnye bolezni (01-02-2015)
    “…Carpal tunnel syndrome (CTS) is a frequent syndrome in adults, but is very rare in children. CTS was described in children with mucopolysaccharidoses (MPS) as…”
    Get full text
    Journal Article
  15. 15

    Use of botulinum toxin type A (Botox) in the treatment of infantile cerebral palsy by A. L. Kurenkov, O. A. Klochkova, B. I. Bursagova, L. M. Kuzenkova, Kh. M. Karimova, A. M. Mamedyarov, A. R. Artemenko, S. A. Petrova

    Published in Nervno-myshechnye bolezni (01-02-2015)
    “…Botulinum toxin type A (BoNT-A) is used in cerebral palsy (CP) for more than 20 years. Nevertheless, the unified protocol of injections and doses does not…”
    Get full text
    Journal Article
  16. 16

    Botulinum toxin type A chemodenervation treatment in spastic forms of cerebral palsy by A. L. Kurenkov, S. S. Nikitin, A. R. Artemenko, B. I. Bursagova, L. M. Kuzenkova, S. A. Petrova, O. A. Klochkova, A. M. Mamedyarov

    Published in Nervno-myshechnye bolezni (01-02-2015)
    “…Cerebral palsy (CP) is one of the most serious outcomes of the perinatal lesion of central nervous system and the most common reason for…”
    Get full text
    Journal Article
  17. 17

    An electromyographic study on the development of optimal tactics of botulinum toxin type A injections in children with spastic forms of cerebral palsy by Kurenkov, A L, Kuzenkova, L M, Burgasova, B I, Petrova, S A, Klochkova, O A, Nikitin, S S, Artemenko, A R, Mamed'iarov, A M

    “…We studied 67 children, aged 2-9 years, with cerebral palsy including 56 children with a spastic form. An electromyographic method was used for the development…”
    Get more information
    Journal Article
  18. 18

    Применение препарата ботулинического токсина типа А (Ботокс) в лечении детского церебрального паралича by Куренков, А Л, Клочкова, О А, Бурсагова, Б И, Кузенкова, Л М, Каримова, Х М, Мамедьяров, А М, Артеменко, А Р, Петрова, С А, Kurenkov, A L, Klochkova, O A, Bursagova, B I, Kuzenkova, L M, Karimova, Kh M, Mamedyarov, A M, Artemenko, A R, Petrova, S A

    Published in Nervno-myshechnye bolezni (01-01-2014)
    “…При детском церебральном параличе (ДЦП) препараты ботулинического токсина типа А (БТА) применяются более 20 лет. Несмотря на это сегодня отсутствует…”
    Get full text
    Journal Article
  19. 19

    Особенности хронической воспалительной демиелинизирующей полинейропатии у детей by Куренков, А Л, Никитин, С С, Бурсагова, Б И, Кузенкова, Л М, Kurenkov, A L, Nikitin, S S, Bursagova, B I, Kuzenkova, L M

    Published in Nervno-myshechnye bolezni (01-01-2012)
    “…Хроническая воспалительная демиелинизирующая полинейропатия (ХВДП) — заболевание периферических нервов аутоиммунной природы, поражающее как взрослых, так и…”
    Get full text
    Journal Article
  20. 20

    Электромиография в диагностике поражения срединного нерва при синдроме запястного канала у детей с мукополисахаридозами by Куренков, А Л, Подклетнова, Т В, Кузенкова, Л М, Бурсагова, Б И, Никитин, С С, Геворкян, А К, Вашакмадзе, Н Д, Kurenkov, A L, Podkletnova, T V, Kuzenkova, L M, Bursagova, B I, Nikitin, S S, Gevorkyan, A K, Vashakmadze, N D

    Published in Nervno-myshechnye bolezni (01-01-2013)
    “…Синдром запястного канала (СЗК) – частое заболевание у взрослых, а у детей встречается крайне редко. У детей с мукополи-сахаридозами (МПС) СЗК описывается как…”
    Get full text
    Journal Article